{
 "cells": [
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "# 00_literature_review\n",
    "\n",
    "Notebook UI for retrieval-backed enzyme literature survey and LLM-generated engineering-focused synthesis."
   ],
   "id": "98108c3d6c086769"
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## Python Path Setup\n",
    "Ensure project-root imports work whether Jupyter starts from repo root or `notebooks/`."
   ],
   "id": "ac84dd1591d6992f"
  },
  {
   "cell_type": "code",
   "metadata": {
    "ExecuteTime": {
     "end_time": "2026-02-12T16:46:51.123121Z",
     "start_time": "2026-02-12T16:46:51.115324Z"
    }
   },
   "source": [
    "from pathlib import Path\n",
    "import os\n",
    "import sys\n",
    "\n",
    "cwd = Path.cwd().resolve()\n",
    "repo_root = cwd.parent if cwd.name == \"notebooks\" else cwd\n",
    "if str(repo_root) not in sys.path:\n",
    "    sys.path.insert(0, str(repo_root))\n",
    "src_root = repo_root / \"src\"\n",
    "if src_root.exists() and str(src_root) not in sys.path:\n",
    "    sys.path.insert(0, str(src_root))"
   ],
   "id": "14b28f4d9d60e50e",
   "outputs": [],
   "execution_count": 1
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## Imports\n",
    "Load helper functions for setup, retrieval, prompt construction, LLM synthesis, and thread persistence."
   ],
   "id": "a168d830dc534522"
  },
  {
   "cell_type": "code",
   "metadata": {
    "ExecuteTime": {
     "end_time": "2026-02-12T16:46:53.458463Z",
     "start_time": "2026-02-12T16:46:52.908787Z"
    }
   },
   "source": [
    "import importlib\n",
    "import agentic_protein_design.steps.literature_review as lr\n",
    "lr = importlib.reload(lr)\n",
    "from project_config.local_api_keys import OPENAI_API_KEY\n",
    "\n",
    "build_literature_agent_prompt = lr.build_literature_agent_prompt\n",
    "default_user_inputs = lr.default_user_inputs\n",
    "generate_literature_llm_review = lr.generate_literature_llm_review\n",
    "init_thread = lr.init_thread\n",
    "persist_thread_update = lr.persist_thread_update\n",
    "run_literature_pipeline = lr.run_literature_pipeline\n",
    "save_literature_llm_review = lr.save_literature_llm_review\n",
    "save_literature_outputs = lr.save_literature_outputs\n",
    "setup_data_root = lr.setup_data_root"
   ],
   "id": "e55a8f9861ec9af0",
   "outputs": [],
   "execution_count": 2
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## API Key Setup\n",
    "Load the OpenAI key from `project_config/local_api_keys.py` into environment variables for LLM calls."
   ],
   "id": "8fbfbb068bb7b39a"
  },
  {
   "cell_type": "code",
   "metadata": {
    "ExecuteTime": {
     "end_time": "2026-02-12T16:48:08.460079Z",
     "start_time": "2026-02-12T16:48:08.455172Z"
    }
   },
   "source": [
    "if OPENAI_API_KEY and OPENAI_API_KEY != \"REPLACE_WITH_YOUR_OPENAI_API_KEY\":\n",
    "    os.environ[\"OPENAI_API_KEY\"] = OPENAI_API_KEY\n",
    "\n",
    "\"OPENAI_API_KEY\" in os.environ"
   ],
   "id": "93a4b67af91040fa",
   "outputs": [
    {
     "data": {
      "text/plain": [
       "True"
      ]
     },
     "execution_count": 8,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "execution_count": 8
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## User Inputs\n",
    "Edit all run parameters here (single place): root/thread selection, literature prompt placeholders, retrieval settings, model, and root-relative input paths."
   ],
   "id": "51427100178a0bb0"
  },
  {
   "cell_type": "code",
   "metadata": {
    "ExecuteTime": {
     "end_time": "2026-02-12T16:47:01.311110Z",
     "start_time": "2026-02-12T16:47:01.306421Z"
    }
   },
   "source": [
    "root_key = \"PIPS2\"\n",
    "existing_thread_id = None\n",
    "\n",
    "user_inputs = {\n",
    "    \"enzyme_family\": \"unspecific peroxygenases (UPOs)\",\n",
    "    \"seed_sequences\": [\"CviUPO\"],\n",
    "    \"reactions_of_interest\": \"peroxygenation of aromatics\",\n",
    "    \"substrates_of_interest\": [\"Veratryl alcohol\", \"Naphthalene\", \"NBD\", \"ABTS\"],\n",
    "    \"application_context\": \"biocatalysis, pharmaceutical synthesis, green chemistry\",\n",
    "    \"constraints\": [\"stability\", \"solvent tolerance\", \"H2O2 tolerance\", \"expression host\"],\n",
    "    \"keywords\": [\"peroxygenation\"],\n",
    "    \"search_sources\": [\n",
    "        \"UniProt\",\n",
    "        \"InterPro\",\n",
    "        \"PDB\",\n",
    "        \"AlphaFold DB\",\n",
    "        \"PubMed\",\n",
    "        \"EuropePMC\",\n",
    "        \"OpenAlex\",\n",
    "        \"WebSearch\",\n",
    "    ],\n",
    "    \"literature_targets\": [\"bioRxiv\", \"Nature\", \"ScienceDirect\", \"PNAS\", \"ACS\", \"Wiley\", \"ChemRxiv\"],\n",
    "    \"evidence_focus\": [\n",
    "        \"protein_annotations\",\n",
    "        \"structure\",\n",
    "        \"reaction_mechanism\",\n",
    "        \"historical_mutations\",\n",
    "    ],\n",
    "    \"max_results_per_source\": 20,\n",
    "    \"fetch_open_access_fulltext\": True,\n",
    "    \"fulltext_max_chars\": 6000,\n",
    "    \"llm_model\": \"gpt-5.2\",\n",
    "    \"llm_temperature\": 0.2,\n",
    "    \"llm_max_rows_per_table\": 250,\n",
    "    \"enable_relaxed_fallback\": True,\n",
    "    \"min_quality_score_for_llm_context\": 0.35,\n",
    "}\n",
    "\n",
    "input_paths = {\n",
    "    # Paths are relative to the data root from project_config.variables.address_dict[root_key].\n",
    "    \"seed_sequences_file\": \"\",\n",
    "    \"constraints_file\": \"\",\n",
    "}\n",
    "\n",
    "# Optional: reset all fields from helper defaults\n",
    "# user_inputs = default_user_inputs()"
   ],
   "id": "c20aa650e4119ed",
   "outputs": [],
   "execution_count": 3
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## Setup Runtime Context\n",
    "Initialize data directories and active chat thread from the values above."
   ],
   "id": "450af271aadb425"
  },
  {
   "cell_type": "code",
   "metadata": {
    "ExecuteTime": {
     "end_time": "2026-02-12T16:47:03.072203Z",
     "start_time": "2026-02-12T16:47:03.061539Z"
    }
   },
   "source": [
    "data_root, resolved_dirs = setup_data_root(root_key)\n",
    "thread, threads_preview = init_thread(root_key, existing_thread_id)\n",
    "thread_id = thread[\"thread_id\"]\n",
    "data_root, thread_id"
   ],
   "id": "9e978af0a0a6e26d",
   "outputs": [
    {
     "data": {
      "text/plain": [
       "(PosixPath('/Users/charmainechia/Documents/projects/PIPS/PIPS2-UPOs-data'),\n",
       " '74b148fa493e4105a47dd5a54ac85b65')"
      ]
     },
     "execution_count": 4,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "execution_count": 4
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## Optional Local Input Files\n",
    "Load optional root-relative files for seed sequences and constraints to enrich the prompt placeholders."
   ],
   "id": "95baa1f5f029f5f7"
  },
  {
   "cell_type": "code",
   "metadata": {
    "ExecuteTime": {
     "end_time": "2026-02-12T16:47:04.656536Z",
     "start_time": "2026-02-12T16:47:04.652105Z"
    }
   },
   "source": [
    "def resolve_input_path(path_value: str) -> Path:\n",
    "    p = Path(path_value).expanduser()\n",
    "    if p.is_absolute():\n",
    "        return p.resolve()\n",
    "    return (data_root / p).resolve()\n",
    "\n",
    "seed_file_val = input_paths.get(\"seed_sequences_file\", \"\").strip()\n",
    "if seed_file_val:\n",
    "    seed_file = resolve_input_path(seed_file_val)\n",
    "    if seed_file.exists():\n",
    "        lines = [l.strip() for l in seed_file.read_text(encoding=\"utf-8\").splitlines() if l.strip()]\n",
    "        if lines:\n",
    "            user_inputs[\"seed_sequences\"] = lines\n",
    "\n",
    "constraints_file_val = input_paths.get(\"constraints_file\", \"\").strip()\n",
    "if constraints_file_val:\n",
    "    constraints_file = resolve_input_path(constraints_file_val)\n",
    "    if constraints_file.exists():\n",
    "        clines = [l.strip() for l in constraints_file.read_text(encoding=\"utf-8\").splitlines() if l.strip()]\n",
    "        if clines:\n",
    "            user_inputs[\"constraints\"] = clines"
   ],
   "id": "fe4555cfb39852b9",
   "outputs": [],
   "execution_count": 5
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## Retrieve And Export\n",
    "Run retrieval against selected protein/literature databases plus optional general web search, then export CSV outputs."
   ],
   "id": "f54bfd9391a4d089"
  },
  {
   "cell_type": "code",
   "metadata": {
    "ExecuteTime": {
     "end_time": "2026-02-12T16:47:43.608236Z",
     "start_time": "2026-02-12T16:47:08.093283Z"
    }
   },
   "source": [
    "outputs = run_literature_pipeline(user_inputs)\n",
    "out_paths = save_literature_outputs(outputs, resolved_dirs[\"processed\"])\n",
    "outputs[\"source_report\"], outputs.get(\"source_debug\"), outputs.get(\"literature_hits\", []).head(10) if hasattr(outputs.get(\"literature_hits\", None), \"head\") else outputs.get(\"literature_hits\"), out_paths"
   ],
   "id": "201c0f93e05b936",
   "outputs": [
    {
     "data": {
      "text/plain": [
       "(                  metric  value\n",
       " 0  total_literature_hits      4\n",
       " 1           biorxiv_hits      0\n",
       " 2            nature_hits      0\n",
       " 3     sciencedirect_hits      0\n",
       " 4       open_access_hits      3\n",
       " 5      high_quality_hits      4\n",
       " 6    medium_quality_hits      0\n",
       " 7       low_quality_hits      0,\n",
       "           source query_mode  \\\n",
       " 0        UniProt    primary   \n",
       " 1       InterPro    primary   \n",
       " 2            PDB    primary   \n",
       " 3   AlphaFold DB    primary   \n",
       " 4         PubMed    primary   \n",
       " 5      EuropePMC    primary   \n",
       " 6       OpenAlex    primary   \n",
       " 7      WebSearch    primary   \n",
       " 8        UniProt    relaxed   \n",
       " 9       InterPro    relaxed   \n",
       " 10           PDB    relaxed   \n",
       " 11  AlphaFold DB    relaxed   \n",
       " 12        PubMed    relaxed   \n",
       " 13     EuropePMC    relaxed   \n",
       " 14      OpenAlex    relaxed   \n",
       " 15     WebSearch    relaxed   \n",
       " \n",
       "                                                 query  rows  \\\n",
       " 0   unspecific peroxygenases (UPOs) CviUPO peroxyg...     0   \n",
       " 1   unspecific peroxygenases (UPOs) CviUPO peroxyg...     0   \n",
       " 2   unspecific peroxygenases (UPOs) CviUPO peroxyg...     0   \n",
       " 3   unspecific peroxygenases (UPOs) CviUPO peroxyg...     0   \n",
       " 4   unspecific peroxygenases (UPOs) CviUPO peroxyg...     0   \n",
       " 5   unspecific peroxygenases (UPOs) CviUPO peroxyg...     0   \n",
       " 6   unspecific peroxygenases (UPOs) CviUPO peroxyg...     0   \n",
       " 7   unspecific peroxygenases (UPOs) CviUPO peroxyg...     0   \n",
       " 8   unspecific peroxygenases (UPOs) CviUPO peroxyg...     0   \n",
       " 9   unspecific peroxygenases (UPOs) CviUPO peroxyg...     0   \n",
       " 10  unspecific peroxygenases (UPOs) CviUPO peroxyg...     0   \n",
       " 11  unspecific peroxygenases (UPOs) CviUPO peroxyg...     0   \n",
       " 12  unspecific peroxygenases (UPOs) CviUPO peroxyg...     3   \n",
       " 13  unspecific peroxygenases (UPOs) CviUPO peroxyg...     1   \n",
       " 14  unspecific peroxygenases (UPOs) CviUPO peroxyg...     0   \n",
       " 15  unspecific peroxygenases (UPOs) CviUPO peroxyg...     0   \n",
       " \n",
       "                                                 error  \n",
       " 0                                                      \n",
       " 1   HTTPError: 503 Server Error: Service Unavailab...  \n",
       " 2   HTTPError: 400 Client Error: Bad Request for u...  \n",
       " 3   HTTPError: 422 Client Error: unknown for url: ...  \n",
       " 4                                                      \n",
       " 5                                                      \n",
       " 6   HTTPError: 400 Client Error: Bad Request for u...  \n",
       " 7                                                      \n",
       " 8                                                      \n",
       " 9   JSONDecodeError: Expecting value: line 1 colum...  \n",
       " 10  HTTPError: 400 Client Error: Bad Request for u...  \n",
       " 11  HTTPError: 422 Client Error: unknown for url: ...  \n",
       " 12                                                     \n",
       " 13                                                     \n",
       " 14  HTTPError: 400 Client Error: Bad Request for u...  \n",
       " 15                                                     ,\n",
       "       source        id                                              title  \\\n",
       " 0     PubMed  39181196  Exploiting UPO versatility to transform rutin ...   \n",
       " 1     PubMed  35453429  Novel Fatty Acid Chain-Shortening by Fungal Pe...   \n",
       " 2     PubMed  31820805  UPObase: an online database of unspecific pero...   \n",
       " 3  EuropePMC  35624779  Engineering <i>Collariella virescens</i> Perox...   \n",
       " \n",
       "                                              journal  year  \\\n",
       " 0                                  New biotechnology  2024   \n",
       " 1                  Antioxidants (Basel, Switzerland)  2022   \n",
       " 2  Database : the journal of biological databases...  2019   \n",
       " 3                                                     2022   \n",
       " \n",
       "                                             abstract  is_open_access  \\\n",
       " 0  The discovery of unspecific peroxygenases (UPO...           False   \n",
       " 1  Unspecific peroxygenases (UPOs), the extracell...            True   \n",
       " 2  There are many unspecific peroxygenases (UPOs)...            True   \n",
       " 3  Vegetable oils are valuable renewable resource...            True   \n",
       " \n",
       "                                         fulltext_url  \\\n",
       " 0                                                      \n",
       " 1  https://pmc.ncbi.nlm.nih.gov/articles/PMC9025384/   \n",
       " 2  https://pmc.ncbi.nlm.nih.gov/articles/PMC6902001/   \n",
       " 3          https://europepmc.org/articles/PMC9137900   \n",
       " \n",
       "                                          url       pmcid  \\\n",
       " 0  https://pubmed.ncbi.nlm.nih.gov/39181196/               \n",
       " 1  https://pubmed.ncbi.nlm.nih.gov/35453429/  PMC9025384   \n",
       " 2  https://pubmed.ncbi.nlm.nih.gov/31820805/  PMC6902001   \n",
       " 3     https://doi.org/10.3390/antiox11050915  PMC9137900   \n",
       " \n",
       "                                           host_venue  \\\n",
       " 0                                  New biotechnology   \n",
       " 1                  Antioxidants (Basel, Switzerland)   \n",
       " 2  Database : the journal of biological databases...   \n",
       " 3                                                      \n",
       " \n",
       "                                     fulltext_excerpt  is_biorxiv  is_nature  \\\n",
       " 0                                                          False      False   \n",
       " 1  pmc Antioxidants (Basel) Antioxidants (Basel) ...       False      False   \n",
       " 2  Database (Oxford) Database (Oxford) 973 databa...       False      False   \n",
       " 3  2840 antiox Antioxidants Antioxidants (Basel) ...       False      False   \n",
       " \n",
       "    is_sciencedirect target_matches  quality_score quality_tier  \n",
       " 0             False                          1.00         high  \n",
       " 1             False                          1.00         high  \n",
       " 2             False                          1.00         high  \n",
       " 3             False                          0.95         high  ,\n",
       " {'literature_summary': PosixPath('/Users/charmainechia/Documents/projects/PIPS/PIPS2-UPOs-data/processed/literature_summary.csv'),\n",
       "  'literature_hits': PosixPath('/Users/charmainechia/Documents/projects/PIPS/PIPS2-UPOs-data/processed/literature_hits.csv'),\n",
       "  'protein_database_hits': PosixPath('/Users/charmainechia/Documents/projects/PIPS/PIPS2-UPOs-data/processed/protein_database_hits.csv'),\n",
       "  'literature_source_report': PosixPath('/Users/charmainechia/Documents/projects/PIPS/PIPS2-UPOs-data/processed/literature_source_report.csv'),\n",
       "  'literature_source_debug.csv': PosixPath('/Users/charmainechia/Documents/projects/PIPS/PIPS2-UPOs-data/processed/literature_source_debug.csv'),\n",
       "  'web_search_hits.csv': PosixPath('/Users/charmainechia/Documents/projects/PIPS/PIPS2-UPOs-data/processed/web_search_hits.csv')})"
      ]
     },
     "execution_count": 6,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "execution_count": 6
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## LLM Literature Synthesis\n",
    "Print the full prompt, call the LLM with retrieval context, and save the generated review."
   ],
   "id": "bb6df9802dd7e88a"
  },
  {
   "cell_type": "code",
   "metadata": {
    "ExecuteTime": {
     "end_time": "2026-02-12T16:49:27.148552Z",
     "start_time": "2026-02-12T16:48:11.619255Z"
    }
   },
   "source": [
    "prompt_text = build_literature_agent_prompt(user_inputs)\n",
    "print(\"=== Prompt Sent To LLM ===\")\n",
    "print(prompt_text)\n",
    "print(\"\\n=== LLM Output ===\")\n",
    "llm_review = generate_literature_llm_review(outputs, user_inputs)\n",
    "print(llm_review)\n",
    "out_llm = save_literature_llm_review(llm_review, resolved_dirs[\"processed\"])\n",
    "out_llm"
   ],
   "id": "7e4ff3a47c555fe8",
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "=== Prompt Sent To LLM ===\n",
      "\n",
      "You are an AI research agent supporting an enzyme engineering project.\n",
      "Your role is to conduct a structured, technically rigorous literature review and generate a concise but insight-dense summary to guide experimental design.\n",
      "\n",
      "INPUTS (provided dynamically)\n",
      "- enzyme_family: unspecific peroxygenases (UPOs)\n",
      "- seed_sequences (optional): CviUPO\n",
      "- reactions_of_interest: peroxygenation of aromatics\n",
      "- substrates_of_interest (optional): Veratryl alcohol Naphthalene NBD ABTS\n",
      "- application_context (optional): biocatalysis, pharmaceutical synthesis, green chemistry\n",
      "- constraints (optional): stability solvent tolerance H2O2 tolerance expression host\n",
      "\n",
      "OBJECTIVE\n",
      "Gather and synthesize current knowledge on:\n",
      "1. Enzyme class structure and fold\n",
      "2. Reaction mechanism (including intermediates, catalytic residues, cofactors)\n",
      "3. Substrate scope and known selectivity trends\n",
      "4. Cofactor requirements and catalytic cycle\n",
      "5. Known engineering efforts (mutagenesis, directed evolution, ML-guided design)\n",
      "6. Stability, expression, and formulation constraints\n",
      "7. Gaps in knowledge and opportunities for engineering\n",
      "\n",
      "SOURCES TO CONSULT\n",
      "- Protein databases: UniProt, PDB, AlphaFold DB, InterPro, Pfam\n",
      "- Literature databases: PubMed, Nature, PNAS, Science, ScienceDirect, ACS, Wiley, bioRxiv, ChemRxiv\n",
      "- Reviews and meta-analyses when available\n",
      "- Structural studies (crystal structures, cryo-EM)\n",
      "- Mechanistic enzymology papers\n",
      "- Directed evolution and protein engineering studies\n",
      "\n",
      "INSTRUCTIONS FOR INFORMATION GATHERING\n",
      "- Prioritize peer-reviewed literature and high-impact reviews.\n",
      "- Distinguish between experimentally validated findings and computational predictions.\n",
      "- Extract quantitative data when possible (kcat, KM, TTN, enantioselectivity, stability metrics, mutation effects).\n",
      "- Identify conserved catalytic residues and structural motifs.\n",
      "- Map engineering-relevant residues (active site, access channel, gating residues, stability hotspots).\n",
      "- Note contradictions or unresolved mechanistic questions.\n",
      "\n",
      "OUTPUT FORMAT\n",
      "\n",
      "1. Executive Summary (<=10 bullet points)\n",
      "   - High-level takeaways most relevant to engineering strategy.\n",
      "\n",
      "2. Structural Overview\n",
      "   - Fold classification\n",
      "   - Domain architecture\n",
      "   - Active site organization\n",
      "   - Access channels / substrate tunnels\n",
      "   - Cofactor binding\n",
      "\n",
      "3. Reaction Mechanism\n",
      "   - Catalytic cycle steps\n",
      "   - Key intermediates\n",
      "   - Rate-limiting steps (if known)\n",
      "   - Competing pathways (e.g. peroxygenation vs peroxidation)\n",
      "   - Determinants of chemoselectivity / regioselectivity\n",
      "\n",
      "4. Substrate Scope & Selectivity Trends\n",
      "   - Classes of substrates accepted\n",
      "   - Structural features tolerated\n",
      "   - Trends in polarity, size, electronics\n",
      "   - Known limitations\n",
      "\n",
      "5. Engineering Landscape\n",
      "   - Mutations known to affect activity/selectivity\n",
      "   - Stability-enhancing mutations\n",
      "   - Expression improvements\n",
      "   - Channel reshaping strategies\n",
      "   - ML-guided or computational design efforts\n",
      "   - Reported performance gains (quantitative if available)\n",
      "\n",
      "6. Practical Constraints\n",
      "   - Cofactor stability (e.g. H2O2 sensitivity)\n",
      "   - Uncoupling / inactivation pathways\n",
      "   - Expression hosts used\n",
      "   - Solvent/temperature/pH tolerance\n",
      "\n",
      "7. Comparative Analysis (if multiple homologs provided)\n",
      "   - Structural or mechanistic differences\n",
      "   - Performance trade-offs\n",
      "   - Known phenotypic clusters\n",
      "\n",
      "8. Engineering Opportunities\n",
      "   - Hypothesis-driven mutation targets\n",
      "   - Channel/gating positions\n",
      "   - Electrostatic tuning opportunities\n",
      "   - Stability engineering strategies\n",
      "   - Assay design suggestions\n",
      "\n",
      "9. References\n",
      "   - Provide full citations (authors, year, journal)\n",
      "   - Include DOI or PubMed ID where available\n",
      "   - Clearly distinguish review vs primary research\n",
      "\n",
      "STYLE REQUIREMENTS\n",
      "- Write clearly and technically, suitable for a PhD-level enzyme engineering audience.\n",
      "- Emphasize mechanistic reasoning and structure-function relationships.\n",
      "- Avoid generic textbook explanations.\n",
      "- Highlight actionable insights for experimental design.\n",
      "- Be concise but information-dense.\n",
      "\n",
      "If seed_sequences are provided:\n",
      "- Identify closest homologs.\n",
      "- Summarize known structures and variants for those sequences.\n",
      "- Highlight residue positions frequently engineered.\n",
      "\n",
      "If reactions_of_interest are specified:\n",
      "- Focus mechanistic discussion on those reaction classes.\n",
      "- Distinguish between productive and competing pathways.\n",
      "\n",
      "The goal is not just to summarize literature, but to extract engineering-relevant insight that can guide rational or ML-assisted enzyme optimization.\n",
      "\n",
      "\n",
      "=== LLM Output ===\n",
      "## 1) Executive Summary (engineering-relevant; \u226410 bullets)\n",
      "\n",
      "- **UPOs are secreted fungal heme\u2011thiolate enzymes (EC 1.11.2.1)** that perform **P450-like oxyfunctionalization** using **H\u2082O\u2082 as the sole cosubstrate** (no NAD(P)H/redox partners), but they also catalyze **peroxidative one\u2011electron oxidations** that can dominate with phenolics/radical-prone substrates.  \n",
      "- **Chemoselectivity (peroxygenation vs peroxidation)** is a central process variable: radical scavengers (e.g., **ascorbate**) can **suppress peroxidative radical coupling/oligomerization** and bias toward **hydroxylated products** (shown for **AaeUPO + rutin**)\u2014a lever directly relevant to aromatic substrates.  \n",
      "- **Active-site access channel geometry is a primary determinant of regio/chemoselectivity**; channel \u201copening\u201d mutations can strongly shift product distributions and increase conversions (e.g., **rCviUPO F88A/T158A** improved epoxidation selectivity/yield in lipids; analogous channel tuning is likely transferable to aromatic peroxygenation).  \n",
      "- **Conserved catalytic architecture**: proximal **Cys thiolate** heme ligand; distal **acid\u2013base (Glu) and Arg** in a conserved motif (UPO signature often reported as **\u2013PCP\u2013EGD\u2013R\u2013E** vs CPO **\u2013PCP\u2013EHD\u2013E**), supporting efficient H\u2082O\u2082 activation.  \n",
      "- **H\u2082O\u2082 tolerance and oxidative inactivation** remain key constraints for scale-up and reuse; membrane reactor reuse of UPO highlighted **activity loss/inactivation during processing** (AaeUPO study), consistent with peroxide-driven heme/protein damage and/or adsorption/denaturation.  \n",
      "- **Assay choice matters**: ABTS/NBD are primarily **peroxidative reporter substrates** (electron transfer), not clean readouts of peroxygenation; for aromatics, use **GC/LC product analytics** (hydroxylation/epoxidation) plus a separate peroxidase assay to quantify competing flux.  \n",
      "- **Sequence space is large and underexploited**: **UPObase** catalogs ~**1948** UPO/UPO-like sequences with subfamily classification and motifs\u2014useful for **homolog mining** for stability/solvent tolerance/expression.  \n",
      "- **Expression**: some UPOs are available recombinantly (notably **rCviUPO in E. coli** for engineering), but many UPOs are secreted glycoproteins where **host choice (fungal/yeast vs E. coli)** impacts folding, secretion, and stability.  \n",
      "- **Opportunity**: engineer (i) **channel/gating residues** to fit aromatics (veratryl alcohol, naphthalene-like), (ii) **surface/stability** for solvent + peroxide tolerance, and (iii) **reaction engineering** (controlled H\u2082O\u2082 delivery + radical quenchers) to suppress peroxidation.\n",
      "\n",
      "---\n",
      "\n",
      "## 2) Structural Overview\n",
      "\n",
      "### Fold classification\n",
      "- **Heme-thiolate peroxidase (HTP) fold**, related to fungal **chloroperoxidase (CPO)** and distinct from classical plant peroxidases. UPOs are often described as **\u201cextracellular P450-like\u201d** due to shared **Cys-thiolate ligation** and Compound I chemistry, but they are **peroxidase-fold enzymes**.\n",
      "\n",
      "### Domain architecture\n",
      "- Typically **single-domain globular enzymes** (~30\u201345 kDa mature protein; many are secreted and may be glycosylated in native hosts).  \n",
      "- Secretory signal peptides in native fungi; recombinant constructs may omit signal peptides or use heterologous secretion signals (host-dependent).\n",
      "\n",
      "### Active site organization\n",
      "- **Heme b** embedded in a pocket with:\n",
      "  - **Proximal Cys** as axial ligand (thiolate \u201cpush\u201d effect).\n",
      "  - **Distal acid\u2013base network** (often **Glu** as general acid/base) and **Arg** assisting peroxide binding/heterolysis.\n",
      "- **Signature motif** reported for UPOs: **\u2013PCP\u2013EGD\u2013R\u2013E** (vs CPO: \u2013PCP\u2013EHD\u2013E), used for annotation/classification (UPObase paper).\n",
      "\n",
      "### Access channels / substrate tunnels\n",
      "- A **heme access channel** connects solvent to the distal face; **channel width/shape and hydrophobicity** govern:\n",
      "  - Substrate entry/pose (regioselectivity on aromatics and aliphatics).\n",
      "  - Partitioning between **oxygen transfer** (peroxygenation) and **outer-sphere electron transfer** (peroxidation) for redox-active aromatics.\n",
      "- Engineering evidence: **alanine scanning / channel residue substitutions** in **rCviUPO** improved oxygenation outcomes (epoxidation case), indicating channel residues are \u201chigh-leverage\u201d knobs.\n",
      "\n",
      "### Cofactor binding\n",
      "- **Noncovalent heme b**; no additional cofactors required.  \n",
      "- Heme incorporation and correct folding can be limiting in heterologous expression (especially in E. coli), often requiring optimized expression conditions.\n",
      "\n",
      "---\n",
      "\n",
      "## 3) Reaction Mechanism (focused on aromatic peroxygenation)\n",
      "\n",
      "### Catalytic cycle steps (consensus for UPOs; experimentally supported by analogy to peroxidases/CPO and UPO mechanistic work)\n",
      "1. **Resting state**: ferric heme (Fe(III)).  \n",
      "2. **H\u2082O\u2082 binding** at distal site \u2192 formation of **Compound 0** (Fe(III)\u2013OOH, hydroperoxo).  \n",
      "3. **O\u2013O heterolysis** (acid\u2013base catalysis by distal residues) \u2192 **Compound I** (Fe(IV)=O + porphyrin/thiolate radical equivalent).  \n",
      "4. **Peroxygenation (oxygen transfer)**: Compound I abstracts H\u2022/e\u207b and inserts O (often via rebound) to yield hydroxylated/epoxidized aromatic products; enzyme proceeds through **Compound II** (Fe(IV)=O) back to Fe(III).  \n",
      "5. **Peroxidation (competing)**: for easily oxidized aromatics/phenolics, Compound I/II can perform **one-electron oxidation** \u2192 substrate radicals \u2192 **coupling/oligomerization** (observed in rutin work).\n",
      "\n",
      "### Key intermediates\n",
      "- **Compound I** and **Compound II** are the central oxidants.  \n",
      "- For some oxygenations (notably epoxidation), a **transient substrate-radical/Compound II* complex** has been proposed in UPO literature (explicitly discussed in the rCviUPO epoxidation paper\u2019s mechanistic framing).\n",
      "\n",
      "### Rate-limiting steps (what is known/likely)\n",
      "- Often governed by a combination of:\n",
      "  - **H\u2082O\u2082 activation efficiency** (distal network).\n",
      "  - **Substrate access/positioning** (channel + binding pocket).\n",
      "  - **Uncoupling/inactivation** at elevated peroxide (process-limited rather than intrinsic kinetics).\n",
      "- Quantitative kinetic constants for the specific aromatic substrates listed (veratryl alcohol, naphthalene, NBD, ABTS) are not in the provided hits; expect strong substrate- and UPO-dependent variability.\n",
      "\n",
      "### Competing pathways: peroxygenation vs peroxidation\n",
      "- **Peroxygenation** desired for aromatic hydroxylation/epoxidation.  \n",
      "- **Peroxidation** dominates with **redox mediators/dyes** (ABTS, many phenolics), generating radicals and side products.\n",
      "- Process lever demonstrated: **ascorbic acid** shifted AaeUPO+rutin toward hydroxylated derivatives by quenching radicals / altering radical chain chemistry (PMID: 39181196).\n",
      "\n",
      "### Determinants of chemo-/regioselectivity\n",
      "- **Channel residues** (sterics) define substrate pose relative to Fe=O.  \n",
      "- **Local polarity/electrostatics** can favor binding of polar aromatics (e.g., veratryl alcohol) vs hydrophobic PAHs (naphthalene).  \n",
      "- **Substrate redox potential** influences likelihood of one-electron oxidation (peroxidation) vs oxygen transfer.\n",
      "\n",
      "---\n",
      "\n",
      "## 4) Substrate Scope & Selectivity Trends (with emphasis on aromatics)\n",
      "\n",
      "### Classes accepted (general UPO capability; supported broadly, though not all quantified in provided hits)\n",
      "- **Aromatics**: hydroxylation, epoxidation, O-/N-dealkylation; also **one-electron oxidations** leading to coupling.  \n",
      "- **Aliphatics**: (sub)terminal hydroxylation, epoxidation of alkenes, fatty-acid oxygenation and even **chain-shortening** (PMID: 35453429).  \n",
      "- **Heteroatom oxidations** and halogenation reported historically for AaeUPO lineage.\n",
      "\n",
      "### Engineering-relevant trends for aromatics\n",
      "- **Bulky/polycyclic aromatics** tend to be limited by **channel size**; \u201copen-channel\u201d variants can expand scope.  \n",
      "- **Phenolic/antioxidant-like substrates** (e.g., rutin) are prone to **peroxidative radical chemistry**; controlling radical pathways is essential for clean peroxygenation.\n",
      "\n",
      "### Known limitations\n",
      "- **Peroxide-driven inactivation** and **radical side reactions** reduce TTN and complicate scale-up.  \n",
      "- **Solubility** of hydrophobic aromatics (naphthalene) necessitates cosolvents\u2014raising solvent tolerance requirements.\n",
      "\n",
      "---\n",
      "\n",
      "## 5) Engineering Landscape (what is directly supported by provided sources + actionable extrapolation)\n",
      "\n",
      "### Mutations affecting activity/selectivity (primary evidence)\n",
      "- **rCviUPO channel engineering** (alanine substitutions; up to six residues) improved oxygenation of unsaturated fatty acids; **F88A/T158A** notably enhanced epoxidation selectivity and process performance (Antioxidants 2022, DOI: 10.3390/antiox11050915).  \n",
      "  - Engineering principle: **reduce steric constraints / reshape channel** to favor productive binding poses and reduce off-pathway reactions.\n",
      "\n",
      "### Stability-enhancing mutations\n",
      "- Not detailed in the provided hits. In UPO practice, stability engineering often targets:\n",
      "  - **Surface charge networks**, **disulfides**, **glycosylation sites** (host-dependent), and **helix capping**; but specific validated mutations require additional primary sources beyond the current hit list.\n",
      "\n",
      "### Expression improvements\n",
      "- **rCviUPO produced in E. coli** (enables rapid mutagenesis/screening) (DOI: 10.3390/antiox11050915).  \n",
      "- Many UPOs are naturally secreted; expression in yeast/fungi can improve folding/glycosylation but slows iteration.\n",
      "\n",
      "### Channel reshaping strategies (validated concept)\n",
      "- **Alanine scanning** of channel residues to map steric hotspots (rCviUPO study).  \n",
      "- For aromatics: analogous approach\u2014identify residues lining the heme channel and mutate to **Ala/Gly/Val/Leu/Phe** to tune size and \u03c0-stacking.\n",
      "\n",
      "### ML-guided/computational design\n",
      "- Not present in provided hits. Practical near-term route: use **UPObase** to build a **sequence\u2013function dataset** (subfamily + motifs + predicted stability features) for ML triage, then test a focused panel experimentally.\n",
      "\n",
      "### Reported performance gains (quantitative from provided hit)\n",
      "- rCviUPO **F88A/T158A**: >80% desired diepoxides after ~99% conversion (lipid case) and up to **85% epoxidation yield** at higher substrate load after process optimization (DOI: 10.3390/antiox11050915). (Not aromatic, but demonstrates magnitude achievable via channel edits + process control.)\n",
      "\n",
      "---\n",
      "\n",
      "## 6) Practical Constraints (stability, H\u2082O\u2082, solvents, expression)\n",
      "\n",
      "### H\u2082O\u2082 sensitivity / inactivation\n",
      "- UPOs require H\u2082O\u2082 but are also **damaged by it** (heme bleaching, oxidative modification, formation of inactive states).  \n",
      "- Process evidence: enzyme reuse in a membrane reactor faced **stability/inactivation challenges** during filtration stages (PMID: 39181196).\n",
      "\n",
      "**Engineering/process mitigations (actionable):**\n",
      "- **Controlled H\u2082O\u2082 feeding** (syringe pump; in situ generation via oxidase) to keep low steady-state peroxide.  \n",
      "- Additives: **radical scavengers** (ascorbate demonstrated), catalase \u201cpolishing\u201d after dosing pulses, or sacrificial reductants depending on product sensitivity.\n",
      "\n",
      "### Solvent tolerance\n",
      "- Not quantified in provided hits; for hydrophobic aromatics expect need for **water-miscible cosolvents** (MeCN, EtOH, DMSO) or biphasic systems. Screen for activity retention and heme integrity.\n",
      "\n",
      "### Expression hosts used\n",
      "- **E. coli** for **rCviUPO** (enables engineering).  \n",
      "- Many canonical UPOs (e.g., AaeUPO) are secreted fungal enzymes; recombinant production often uses yeast/fungal systems in broader literature (not in provided hits).\n",
      "\n",
      "### Formulation/immobilization\n",
      "- Membrane reactor reuse suggests immobilization/recovery is feasible but **mechanical/processing stress + peroxide** can accelerate deactivation (PMID: 39181196). Consider gentle immobilization chemistries and peroxide control.\n",
      "\n",
      "---\n",
      "\n",
      "## 7) Comparative Analysis (seed sequence: CviUPO; limited by provided data)\n",
      "\n",
      "- **CviUPO (Collariella virescens UPO)** is explicitly demonstrated as **engineerable in E. coli** and responsive to **heme-channel mutations** (F88A/T158A).  \n",
      "- **AaeUPO (Agrocybe/Cyclocybe aegerita UPO)** is highlighted for aromatic/phenolic transformations where **peroxidation vs peroxygenation** competition is prominent (rutin case).  \n",
      "- Trade-off hypothesis: **more open channels** may increase turnover on bulky/hydrophobic substrates but can also increase **uncoupling** or **peroxidative side reactions** by allowing alternative binding modes\u2014needs empirical mapping for aromatics.\n",
      "\n",
      "---\n",
      "\n",
      "## 8) Engineering Opportunities (specific, testable hypotheses for aromatic peroxygenation)\n",
      "\n",
      "### A. Channel/gating residue targets (CviUPO-centric)\n",
      "- Start from the validated **heme-channel hotspot positions F88 and T158** (CviUPO numbering per the Antioxidants 2022 paper).  \n",
      "  - For aromatics: test **F88A/F88V/F88L/F88Y** (sterics + \u03c0 interactions) and **T158A/T158V/T158S** (size/polarity).  \n",
      "  - Combine with second-shell mutations to restore binding specificity if activity becomes too \u201cleaky\u201d.\n",
      "\n",
      "### B. Biasing peroxygenation over peroxidation (process + protein)\n",
      "- **Assay with and without radical scavengers** (ascorbate; possibly Trolox) to quantify peroxidation contribution for each substrate (veratryl alcohol vs naphthalene vs ABTS/NBD).  \n",
      "- Protein-side: introduce **more hydrophobic/shape-complementary binding** near the oxoferryl to favor close-contact oxygen transfer over outer-sphere ET (requires structure/model; see below).\n",
      "\n",
      "### C. Electrostatic tuning\n",
      "- For polar aromatics (veratryl alcohol), add **H-bond donors/acceptors** in the channel to preorganize the benzylic C\u2013H near Fe=O.  \n",
      "- For PAHs (naphthalene), reduce polar \u201ctraps\u201d and increase **hydrophobic packing** to improve occupancy.\n",
      "\n",
      "### D. Stability / H\u2082O\u2082 tolerance strategy\n",
      "- Screen for variants with improved **residual activity after peroxide challenge** (e.g., incubate with 1\u201310 mM H\u2082O\u2082 for defined times; measure remaining peroxygenation activity).  \n",
      "- Couple with **low-peroxide feed** in preparative reactions; many \u201cstability\u201d gains are realized by process control rather than mutations alone.\n",
      "\n",
      "### E. Assay design suggestions (to avoid misleading readouts)\n",
      "- Use **two orthogonal assays**:\n",
      "  1) **Peroxygenation analytics**: LC/GC quantification of hydroxylated/epoxidized products for veratryl alcohol and naphthalene.  \n",
      "  2) **Peroxidation reporter**: ABTS oxidation rate to quantify one-electron activity (useful as a \u201cside reaction\u201d metric, not as the main objective).\n",
      "- Include **H\u2082O\u2082 consumption** and **enzyme inactivation kinetics** (activity vs time) to estimate TTN under realistic dosing.\n",
      "\n",
      "### F. Homolog mining (UPObase-driven)\n",
      "- Use **UPObase** to select homologs in different subfamilies with:\n",
      "  - Predicted **higher thermostability** (more salt bridges, shorter loops),\n",
      "  - Different **channel motifs** (bulky vs open),\n",
      "  - Better **expression compatibility** (fewer disulfides/glycosylation dependence for E. coli).\n",
      "- Build a small panel (10\u201330 enzymes) for rapid functional screening on your aromatic substrates.\n",
      "\n",
      "---\n",
      "\n",
      "## 9) References (provided hits; review vs primary)\n",
      "\n",
      "1. **(Primary research)** Linde, D.; Gonz\u00e1lez-Benjumea, A.; Aranda, C.; Carro, J.; Guti\u00e9rrez, A.; Mart\u00ednez, A. T. (2022). *Engineering Collariella virescens Peroxygenase for Epoxides Production from Vegetable Oil.* **Antioxidants** 11(5):915. DOI: **10.3390/antiox11050915**. PMCID: **PMC9137900**.  \n",
      "2. **(Primary research / process + selectivity control)** (2024). *Exploiting UPO versatility to transform rutin in more soluble and bioactive products.* **New Biotechnology**. PubMed: **PMID 39181196**.  \n",
      "3. **(Primary research)** Olmedo, A.; Ullrich, R.; Hofrichter, M.; del R\u00edo, J. C.; Mart\u00ednez, \u00c1. T.; Guti\u00e9rrez, A. (2022). *Novel Fatty Acid Chain-Shortening by Fungal Peroxygenases Yielding 2C-Shorter Dicarboxylic Acids.* **Antioxidants** 11(4):744. DOI: **10.3390/antiox11040744**. PMCID: **PMC9025384**.  \n",
      "4. **(Database/resource)** Muniba, F.; Dongming, L.; Huang, S.; Wang, Y. (2019). *UPObase: an online database of unspecific peroxygenases.* **Database (Oxford)**. DOI: **10.1093/database/baz122**. PMCID: **PMC6902001**.\n",
      "\n",
      "---\n",
      "\n",
      "### What I would request next (to sharpen this for CviUPO + aromatics)\n",
      "If you can provide **CviUPO sequence/construct** (or UniProt/GenBank ID) and any **existing activity data** on veratryl alcohol/naphthalene, I can (i) map **channel residues around F88/T158** onto an AlphaFold/PDB model, (ii) propose a **focused mutational library** (\u226450 variants) with predicted effects on aromatic binding poses, and (iii) recommend **H\u2082O\u2082 feed regimes** and analytics tailored to your substrates (including how to treat ABTS/NBD as side-activity controls).\n"
     ]
    },
    {
     "data": {
      "text/plain": [
       "PosixPath('/Users/charmainechia/Documents/projects/PIPS/PIPS2-UPOs-data/processed/literature_review_llm_summary.md')"
      ]
     },
     "execution_count": 9,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "execution_count": 9
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## Save Thread Update\n",
    "Run this final cell to append run metadata and compact LLM summary to `chats/<llm_process_tag>_<thread_id>.json`."
   ],
   "id": "91e017246a72879d"
  },
  {
   "cell_type": "code",
   "metadata": {
    "ExecuteTime": {
     "end_time": "2026-02-12T16:49:58.335727Z",
     "start_time": "2026-02-12T16:49:58.327413Z"
    }
   },
   "source": [
    "persist_thread_update(\n",
    "    root_key=root_key,\n",
    "    thread_id=thread_id,\n",
    "    inputs=user_inputs,\n",
    "    out_paths=out_paths,\n",
    "    llm_review_path=out_llm,\n",
    "    llm_review_text=llm_review,\n",
    ")"
   ],
   "id": "8c2b1910499d4aef",
   "outputs": [
    {
     "data": {
      "text/plain": [
       "'2026-02-12T16:49:58.332639+00:00'"
      ]
     },
     "execution_count": 10,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "execution_count": 10
  },
  {
   "metadata": {},
   "cell_type": "code",
   "source": "",
   "id": "3e08e4e04ca2c3e8",
   "outputs": [],
   "execution_count": null
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "Python 3",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "name": "python",
   "version": "3.11"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 5
}